A PI-RADS-Based New Nomogram for Predicting Clinically Significant Prostate Cancer: A Cohort Study

PURPOSE: To develop and validate a PI-RADS-based nomogram for predicting the probability of clinically significant prostate cancer (csPCa) at initial prostate biopsy. PATIENTS AND METHODS: From February 2015 to October 2018, 573 consecutive patients made up the development cohort (DC), and another 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yueyue, Zhu, Guiqi, Zhao, Wenlu, Wei, Chaogang, Chen, Tong, Ma, Qi, Zhang, Yongsheng, Xue, Boxin, Shen, Junkang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245434/
https://www.ncbi.nlm.nih.gov/pubmed/32547200
http://dx.doi.org/10.2147/CMAR.S250633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245434/
https://www.ncbi.nlm.nih.gov/pubmed/32547200
http://dx.doi.org/10.2147/CMAR.S250633

Ejemplares similares